Have a feature idea you'd love to see implemented?
Let us know!
AWH Aspira Women's Health Inc
Price (delayed)
$0.97
Market cap
$15.58M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.42
Enterprise value
$16.98M
Aspira Women's Health Inc. operates as a biotech company. The Company develops and discovers testing and treatments for gynecologic issues. Aspira Women's Health serves customers in the State of Texas.
Highlights
The EPS has grown by 45% YoY
The debt has declined by 12% since the previous quarter
The net income has grown by 25% year-on-year but it has declined by 8% since the previous quarter
The company's equity has shrunk by 172% QoQ
The company's quick ratio has shrunk by 61% YoY and by 55% QoQ
Key stats
What are the main financial stats of AWH
Market
Valuations
Earnings
Shares outstanding
16.06M
Market cap
$15.58M
Enterprise value
$16.98M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1.36
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.9
Revenue
$8.92M
EBIT
-$15.94M
EBITDA
-$15.83M
Free cash flow
-$14.99M
Per share
Balance sheet
Liquidity
EPS
-$1.42
Free cash flow per share
-$1.2
Book value per share
-$0.3
Revenue per share
$0.71
TBVPS
$0.32
Total assets
$3.96M
Total liabilities
$7.67M
Debt
$2.36M
Equity
-$3.71M
Working capital
-$2.21M
Debt to equity
-0.64
Current ratio
0.6
Quick ratio
0.44
Net debt/EBITDA
-0.09
Margins
Efficiency
Dividend
EBITDA margin
-177.4%
Gross margin
57.8%
Net margin
-178.8%
Operating margin
-194.5%
Return on assets
-245%
Return on equity
N/A
Return on invested capital
-2,648.8%
Return on capital employed
N/A
Return on sales
-178.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AWH stock price
How has the Aspira Women's Health stock price performed over time
Intraday
-1.02%
1 week
13.76%
1 month
23.41%
1 year
-81.94%
YTD
-76.23%
QTD
19.75%
Financial performance
How have Aspira Women's Health's revenue and profit performed over time
Revenue
$8.92M
Gross profit
$5.16M
Operating income
-$17.35M
Net income
-$15.95M
Gross margin
57.8%
Net margin
-178.8%
The operating income has grown by 29% year-on-year
Aspira Women's Health's operating margin has increased by 28% YoY
The net income has grown by 25% year-on-year but it has declined by 8% since the previous quarter
The net margin has increased by 24% year-on-year but it has declined by 9% since the previous quarter
Growth
What is Aspira Women's Health's growth rate over time
Valuation
What is Aspira Women's Health stock price valuation
P/E
N/A
P/B
N/A
P/S
1.36
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.9
The EPS has grown by 45% YoY
The company's equity has shrunk by 172% QoQ
AWH's price to sales (P/S) is 96% less than its 5-year quarterly average of 38.4 and 66% less than its last 4 quarters average of 4.0
Efficiency
How efficient is Aspira Women's Health business performance
The ROA has plunged by 74% YoY and by 24% from the previous quarter
The ROS has grown by 24% YoY but it has contracted by 9% from the previous quarter
Aspira Women's Health's ROIC has increased by 20% YoY but it has decreased by 20% from the previous quarter
Dividends
What is AWH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AWH.
Financial health
How did Aspira Women's Health financials performed over time
Aspira Women's Health's total assets is 48% less than its total liabilities
The company's quick ratio has shrunk by 61% YoY and by 55% QoQ
The company's current ratio has shrunk by 53% YoY and by 48% QoQ
The debt is 164% greater than the equity
The company's equity has shrunk by 172% QoQ
Aspira Women's Health's debt to equity has soared by 85% YoY and by 68% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.